MODERATOR
:
SPEAKER
(S):
Steven Spitalnik, MD, Professor, Columbia University
Mark Looney, MD, Associate Professor of Medicine, University of California, San Francisco
The role of antibodies in the pathogenesis of TRALI
Christopher Silliman, MD, PhD, FAAP, Senior Independent Investigator/Professor (tenured), Bonfils Blood Center/Univ of CO at Denver Sch Med
Two-event in vivo Models of Transfusion-Related Acute Lung Injury (TRALI)
Description
The overall goal of this session is to discuss how the use of murine models (i.e. rats and mice) can improve the understanding of the role of leukocytes in TRALI. An overall introduction to the problem, including a description of TRALI and the relevance of using murine models in transfusion medicine, will be provided. Two leading experts who actively use murine models to investigate TRALI pathogenesis will address the role of antibodies and the one-hit hypothesis in the pathogenesis of TRALI and the role of bioactive lipids and the two-hit hypothesis in the pathogenesis of TRALI. Because the results obtained from these models remain somewhat controversial and because their applicability to humans is still under study, the session will end with a question and answer period that will engage the audience in discussion.
-
Describe the role of bioactive lipids and the two-hit hypothesis in TRALI.
-
Discuss the role of antibodies and the one-hit hypothesis in Transfusion Related Acute Lung Injury (TRALI).
-
Use the current knowledge regarding TRALI pathogenesis to develop treatment and/or prevention strategies.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.